AMLにおける移植前リスク予測の限界の定義:機械学習と回帰モデルの証拠
Ashish Narayan Masurekar1, Kelly M Burkett2, Arya Rahgozar3
1Transplant & Cellular Therapy, The Ottawa Hospital, 501 Smyth Road, Ottawa, Ontario, Canada, K1H8L6; The Ottawa Hospital Research Institute, 1053 Carling Avenue, Ottawa, Ontario, Canada, K1Y 4E9; Faculty of Medicine, University of Ottawa, 75 Laurier Avenue E, Ottawa, Ontario, Canada, K1N 4E9.
Transplantation and cellular therapy
|January 2, 2026
まとめ
No abstract available in PubMed .
さらに関連する動画
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
470
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
524
